CD8A and neoplasm: CD8+ T cells in the HNSCC TME interactome, particularly with macrophages, are based on predicted CD274–PDCD1, HAVCR2–LGALS9, and TIGIT–NECTIN2 interactions that may dictate tumor rejection.